Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christopher K. Rushton
The Double Hit Signature Identifies Double-Hit Diffuse Large B-Cell Lymphoma With Genetic Events Cryptic to FISH
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Related publications
Cryptic Myc and Bcl2 Rearrangements Are Among a Range of Genetic Mechanisms Underlying the Double Hit Signature in Non-Double Hit Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Double-Hit B-Cell Lymphomas
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Transformation of Double-Hit Large B-Cell Lymphoma Into B-Lymphoblastic Lymphoma: A Case Report
Journal of Hematopathology
Forensic Medicine
Pathology
Hematology
Histology
Double‐hit Lymphoma: So What?
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Diffuse Large B-Cell Lymphoma With Combined TP53 Mutation and MIR34A Methylation: Another &Ldquo;double Hit” Lymphoma With Very Poor Outcome?
Oncotarget
Oncology
Drug Therapy for Double-Hit Lymphoma
Drugs in Context
Molecular Medicine
Pharmacology
Immunohistochemical Double Hit Score Enhances NCCN-IPI and Is Associated With Detrimental Outcomes in Refractory or Relapsing Patients With Diffuse Large B Cell Lymphoma
British Journal of Haematology
Hematology
Double Hit and Double Expressors in Lymphoma: Definition and Treatment
Cancer
Cancer Research
Oncology
Young High Risk Patients With Diffuse Large B-Cell Lymphoma Including BCL-2/Myc Double Hit Lymphomas Benefit From Dose-Dense Immunochemotherapy With Early CNS Prophylaxis
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology